# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-024101
Filing Date
2025-08-14
Accepted
2025-08-14 16:45:50
Documents
67
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1071037
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 11996
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 12025
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 5358
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 5690
6 | GRAPHIC | form10-q_001.jpg | GRAPHIC | 6470
| Complete submission text file | 0001641172-25-024101.txt |  | 5742407

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | tvgn-20250630.xsd | EX-101.SCH | 39911
8 | XBRL CALCULATION FILE | tvgn-20250630_cal.xml | EX-101.CAL | 52138
9 | XBRL DEFINITION FILE | tvgn-20250630_def.xml | EX-101.DEF | 257388
10 | XBRL LABEL FILE | tvgn-20250630_lab.xml | EX-101.LAB | 393253
11 | XBRL PRESENTATION FILE | tvgn-20250630_pre.xml | EX-101.PRE | 337071
69 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 794086

Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41002 | Film No.: 251220355
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)